Zydus Lifesciences inks first amendment agreement to acquire additional stake in AMP

03 Nov 2022 Evaluate

Zydus Lifesciences has entered into First Amendment agreement to the Share Purchase, Subscription and Shareholder’s Agreement (SPSSA) on November 2, 2022 to acquire additional stake of 0.31% on a fully diluted basis in AMP Energy Green Nine (AMP), resulting into aggregate stake of 12.17% on a fully diluted basis in AMP. Earlier, the company had entered into Share Purchase, Subscription and Shareholder’s Agreement to acquire upto 11.86% stake on a fully diluted basis in AMP Energy Green Nine.

In line with the Company’s commitment to enhance the share of renewable power source in its operation and to comply with regulatory requirement for being a captive user under Electricity Laws, 2003, the Company will acquire up to 12.17% stake, in one or more tranches, on fully diluted basis in AMP throughout the term of the definitive agreements i.e., Power Purchase Agreement, SPSSA and First Amendment Agreement to SPSSA.

Zydus Lifesciences (formerly known as Cadila Healthcare) is an India-based pharmaceutical company.

Zydus Lifesciences Share Price

901.00 11.10 (1.25%)
18-Mar-2026 15:58 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1780.00
Dr. Reddys Lab 1287.00
Cipla 1268.20
Zydus Lifesciences 901.00
Lupin 2295.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×